Development and Validation of an All-Cause Mortality Risk Score in Type 2 Diabetes The Hong Kong Diabetes Registry - Wikidata - awgldk - TriplyDB

Development and Validation of an All-Cause Mortality Risk Score in Type 2 Diabetes The Hong Kong Diabetes Registry

Development and Validation of an All-Cause Mortality Risk Score in Type 2 Diabetes The Hong Kong Diabetes Registry

http://www.wikidata.org/entity/Q58209674

about

Evidence for DNA damage as a biological link between diabetes and cancer What can we learn from the recent blood glucose lowering megatrials?From design to implementation--the Joint Asia Diabetes Evaluation (JADE) program: a descriptive report of an electronic web-based diabetes management program Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry.Validation of methods to control for immortal time bias in a pharmacoepidemiologic analysis of renin-angiotensin system inhibitors in type 2 diabetes.Hypoglycaemia, chronic kidney disease and death in type 2 diabetes: the Hong Kong diabetes registry Evaluation of the quality of care of a multi-disciplinary risk factor assessment and management programme (RAMP) for diabetic patients.Low HDL cholesterol, metformin use, and cancer risk in type 2 diabetes: the Hong Kong Diabetes Registry.A summary risk score for the prediction of Alzheimer disease in elderly persons Using a multi-staged strategy based on machine learning and mathematical modeling to predict genotype-phenotype risk patterns in diabetic kidney disease: a prospective case-control cohort analysis.The Complexity of Vascular and Non-Vascular Complications of Diabetes: The Hong Kong Diabetes Registry.Use of net reclassification improvement (NRI) method confirms the utility of combined genetic risk score to predict type 2 diabetes.Predictors of all-cause and cardiovascular disease mortality in type 2 diabetes: Diabetes Heart Study.Predictors of mortality over 8 years in type 2 diabetic patients: Translating Research Into Action for Diabetes (TRIAD)A validated risk calculator to assess risk and rate of visual field progression in treated glaucoma patients.Predictive Mortality Index for Community-Dwelling Elderly Koreans.Development and validation of a risk score for hospitalization for heart failure in patients with Type 2 diabetes mellitus.Predicting macro- and microvascular complications in type 2 diabetes: the Japan Diabetes Complications Study/the Japanese Elderly Diabetes Intervention Trial risk engine Independent associations between low-density lipoprotein cholesterol and cancer among patients with type 2 diabetes mellitus Prediction of morbidity and mortality in patients with type 2 diabetes Aldose reductase genotypes and cardiorenal complications: an 8-year prospective analysis of 1,074 type 2 diabetic patients.Additive interaction of hyperglycemia and albuminuria on risk of ischemic stroke in type 2 diabetes: Hong Kong Diabetes Registry.Development and validation of a predicting model of all-cause mortality in patients with type 2 diabetes.Effect of interactions between C peptide levels and insulin treatment on clinical outcomes among patients with type 2 diabetes mellitus.Additive interaction between the renin-angiotensin system and lipid metabolism for cancer in type 2 diabetes.Low LDL cholesterol, albuminuria, and statins for the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry Interactive effect of serum uric acid and total bilirubin for cardiovascular disease in Chinese patients with type 2 diabetes.Development and validation of Risk Equations for Complications Of type 2 Diabetes (RECODe) using individual participant data from randomised trials.Comprehensive risk assessments of diabetic patients from seven Asian countries: The Joint Asia Diabetes Evaluation (JADE) program.Pregnancy and diabetes scenario around the world: China.Cost-effectiveness of cytochrome P450 2C19 *2 genotype-guided selection of clopidogrel or ticagrelor in Chinese patients with acute coronary syndrome.A four-year cardiovascular risk score for type 2 diabetic inpatients.Clinical characteristics of Chinese patients with duration of type 2 diabetes >40 years.A Point-based Mortality Prediction System for Older Adults with Diabetes.Synergistic effects of low LDL cholesterol with other factors for the risk of cancer in type 2 diabetes: the Hong Kong Diabetes Registry.Predictive models for all-cause and cardiovascular mortality in type 2 diabetic inpatients. A cohort study.Low triglyceride as a marker for increased risk of cardiovascular diseases in patients with long-term type 2 diabetes: A cross-sectional survey in China.A transient improvement in renal function occurs after ischemic stroke.Renin angiotensin system inhibitors may attenuate low LDL cholesterol-related cancer risk in type 2 diabetes

P2860

Q27001226-E02EDD0E-892B-4348-BDCF-A0FD56C85225 Q33558383-F40906CE-6429-4734-8F4E-21055277F52A Q33577432-34FD8D0B-F9A9-48BD-8240-BA73DD66294A Q33803499-B758BC15-A948-41DC-96E9-FAC93FD81E38 Q33819587-A084AB3E-9D6B-49F3-B8FB-2B02E3048C4E Q34116963-2DAA6678-F008-4CF2-949E-2048D98F9002 Q34502293-172C5A50-FB63-4933-8356-D555D07EB038 Q34507157-45ED06C7-754D-4DBE-A4E6-93920157EFE8 Q34747831-B4196D29-6481-44F9-B3EB-754E7BF48385 Q34859942-A45792F0-DC0F-44FF-9CA3-B8A2802693A4 Q34893020-494F52A3-7717-4016-926B-BE3C0800D43E Q35077910-E90CFDCE-4590-4170-88C8-7A4249521112 Q35814812-51303C7A-3EC9-40AB-B9C3-5DB0B55E6CA7 Q35976486-A883000B-4B8A-4A81-87A1-31B69232A58D Q36390585-83C8985C-A48E-43BF-BCA4-AA0779B42E66 Q36566995-82D4E100-4871-45BB-A792-C32A63B51DB3 Q36649245-779D12D8-7E16-423C-9AC6-C9800F6B6427 Q36782615-2A09A9F1-BEC0-46B5-A18E-6F9C24A61B5E Q36841591-4599E139-2EB0-4C58-AA0B-074E7BD1D6EC Q36936666-A533BB5E-3CDF-47EE-8D12-B7695459EB3C Q36945298-9626716A-1225-44DC-944A-8CCAD5FD8AB2 Q36975675-1A70CC7A-9112-4494-B615-7A9923C5AA2E Q37106533-D6950F10-D9CC-437B-8415-FFCF63D95BCA Q37163138-4262BF14-0654-4BAD-A99A-8C802180293E Q37236318-6C7F412C-31FF-4C10-8372-9C06C7B16E03 Q37364995-B59032A5-8C46-4517-B2B8-ECFB8CDD8E86 Q37386378-B017105B-F3E3-4ED8-BE77-7AF34A42176B Q38627117-81EFDDBA-18DB-4698-8682-F1B8A73EFD78 Q39983936-55B55A2D-4A36-40FC-98B6-3F3DAC35318D Q40009683-2147D758-6798-4B79-99F6-2B7EE7E1B30D Q40366831-401B1135-9393-4B96-B742-B25AFB3E568B Q40855717-6452505B-FD00-4D0B-A1EC-64CADADA6A21 Q40985610-C5865447-2CAB-4643-AC35-B2B974D95A10 Q42281548-A6D5AF42-A073-428A-8001-443D0F8270A8 Q44107851-FBA3ABD2-367C-41D3-A41A-BE0F9DF22A21 Q48209843-8C2F83D5-C8CE-44CA-B94D-23453E1B5677 Q48327312-D9F1C299-9C6B-4809-B7B6-2021D45D9EBF Q48823339-CA16F8D6-3D32-48E2-8342-35F7C55FB590 Q58209417-6C252D7B-2354-4319-BFF0-6E6FAFA688E4

P2860

Development and Validation of an All-Cause Mortality Risk Score in Type 2 Diabetes The Hong Kong Diabetes Registry

http://www.wikidata.org/entity/Q58209674

description

article

@en

im März 2008 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в березні 2008

@uk

name

Development and Validation of ...... he Hong Kong Diabetes Registry

@en

Development and Validation of ...... he Hong Kong Diabetes Registry

@nl

type

label

Development and Validation of ...... he Hong Kong Diabetes Registry

@en

Development and Validation of ...... he Hong Kong Diabetes Registry

@nl

prefLabel

Development and Validation of ...... he Hong Kong Diabetes Registry

@en

Development and Validation of ...... he Hong Kong Diabetes Registry

@nl

P1433

Q58209674-8FAFF61E-9FCA-48CC-807E-A5ECD236C60C

P1476

Q58209674-7BB73718-6E52-4476-8FDD-A36AA3AD93E0

P2093

Q58209674-028C2467-DE50-4E35-A569-D30B39F8852B

Q58209674-214A2C9E-5992-42D2-92CB-3A8D23CD3E85

Q58209674-6079B0AE-E9E7-4EA3-9632-594F39AD0F6F

Q58209674-73ED1329-D21C-4AA3-BF9F-BB630D2C3EBD

Q58209674-75E3D3B9-5546-4E15-AC55-E54CAC00D2EF

Q58209674-87AA3D5A-2F1B-488D-8874-1DF6064E26D0

Q58209674-8EFADB17-A41F-443A-A200-ACF3C49F06AF

Q58209674-AB44E680-A378-4872-BBAE-DB1A0459A1AC

Q58209674-D9698410-DFD3-4564-8DB2-091AA5B22731

Q58209674-EDAD49DE-A8AA-4A71-8395-DAF045DA2A32

P304

Q58209674-1A3C9742-3BB9-44A4-BBC6-0987B0E00007

P31

Q58209674-9DB1B2E2-8519-4A3C-A48A-BC8001F17C35

P356

Q58209674-71A71BD8-1A37-46AE-827D-7FD1E5D0ABC2

P407

Q58209674-5B3C9E9E-575E-4937-B33D-AC0AE18BAC3F

P433

Q58209674-524B726B-448B-43A3-97E0-9B8772D928F2

P478

Q58209674-939A698B-D42D-4BF6-BC94-EF4B33560ACF

P50

Q58209674-A63A1BD0-E83E-4A65-A66A-C1E76A52C258

Q58209674-B7341432-4C06-4482-AAE0-D9081A0013B2

P577

Q58209674-7AD83F74-5E3D-4B10-9D2D-2F5F81F8ED82

P698

Q58209674-1EFD6EE6-B669-4432-A51F-6835E8F3D75A

P921

Q58209674-D097081F-2220-49FB-9F25-493E7B87E14B

P356

ARCHINTE.168.5.451

P1433

JAMA Internal Medicine

P1476

Development and validation of an all-cause mortality risk score in type 2 diabetes

@en

P2093

Alice P S Kong

http://www.w3.org/2001/XMLSchema#string

Christopher W K Lam

http://www.w3.org/2001/XMLSchema#string

Chun-Chung Chow

http://www.w3.org/2001/XMLSchema#string

Chung Shun Ho

http://www.w3.org/2001/XMLSchema#string

Clive S Cockram

http://www.w3.org/2001/XMLSchema#string

Gary T C Ko

http://www.w3.org/2001/XMLSchema#string

Hong Kong Diabetes Registry

http://www.w3.org/2001/XMLSchema#string

Peter C Y Tong

http://www.w3.org/2001/XMLSchema#string

Vivian C W Wong

http://www.w3.org/2001/XMLSchema#string

Wing Yee So

http://www.w3.org/2001/XMLSchema#string

P304

451-457

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHINTE.168.5.451

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

168

http://www.w3.org/2001/XMLSchema#string

P50

Juliana Chung-ngor Chan

Ronald Ching Wan Ma

P577

2008-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18332288

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes